(1)

Annex II to the Agreement was amended by Decision of the EEA Joint Committee No 79/2007 of 6 July 2007 (1).

(2)

Commission Recommendation 2006/583/EC of 17 August 2006 on the prevention and reduction of Fusarium toxins in cereals and cereal products (2) is to be incorporated into the Agreement.

(3)

Commission Directive 2006/142/EC of 22 December 2006 amending Annex IIIa of Directive 2000/13/EC of the European Parliament and of the Council listing the ingredients which must under all circumstances appear on the labelling of foodstuffs (3) is to be incorporated into the Agreement.

(4)

Commission Regulation (EC) No 2023/2006 of 22 December 2006 on good manufacturing practice for materials and articles intended to come into contact with food (4) is to be incorporated into the Agreement.

(5)

Commission Directive 2007/7/EC of 14 February 2007 amending certain Annexes to Council Directives 86/362/EEC and 90/642/EEC as regards the maximum residue levels of atrazine, lambda-cyhalothrin, phenmedipham, methomyl, linuron, penconazole, pymetrozine, bifenthrin and abamectin (5) is to be incorporated into the Agreement.

(6)

Commission Directive 2007/12/EC of 26 February 2007 amending certain Annexes to Council Directive 90/642/EEC as regards the maximum residue levels of penconazole, benomyl and carbendazim (6) is to be incorporated into the Agreement.

(7)

Commission Directive 2007/8/EC of 20 February 2007 amending Annexes to Council Directives 76/895/EEC, 86/362/EEC and 90/642/EEC as regards maximum residue levels for phosphamidon and mevinphos (7) is to be incorporated into the Agreement.

(8)

Commission Directive 2007/9/EC of 20 February 2007 amending the Annexe to Council Directive 90/642/EEC as regards maximum residue levels for aldicarb (8) is to be incorporated into the Agreement.

(9)

Commission Directive 2007/11/EC of 21 February 2007 amending certain Annexes to Council Directives 86/362/EEC, 86/363/EEC and 90/642/EEC as regards maximum residue levels for acetamiprid, thiacloprid, imazosulfuron, methoxyfenozide, S-metholachlor, milbemectin and tribenuron (9) is to be incorporated into the Agreement,

1.

the following indent shall be added in point 13 (Council Directive 76/895/EEC):

2.

the following indent shall be added in point 18 (Directive 2000/13/EC of the European Parliament and of the Council):

3.

the following indents shall be added in point 38 (Council Directive 86/362/EEC):

4.

the following indent shall be added in point 39 (Council Directive 86/363/EEC):

5.

the following indents shall be added in point 54 (Council Directive 90/642/EEC):

6.

the following point shall be inserted after point 54zzza (Commission Directive 2006/125/EC):

7.

under the heading ‘ACTS OF WHICH THE CONTRACTING PART IES SHALL TAKE NOTE’ the following point shall be inserted after point 60 (Commission Recommendation 2005/108/EC):